1 Literaturstellen gefunden
- Chen, Shihui and Zhao, Xiaolan and Wan, Jing and Ran, Li and Qin, Yu and Wang, Xiaofang and Gao, Yanxiang and Shu, Furong and Zhang, Yong and Liu, Peng and Zhang, Qianyong and Zhu, Jundong and Mi, Mantian (2015). Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial. Pharmacological Research [Chen2015] DOI